Besides, Li et al. (2019) have revealed that m6A reader IGF2BP3 maybe a potential oncogene for ccRCC and other 32 cancers through a pan-cancer analysis the study was mainly to investigate the general rule of m6A regulators across 33 cancer types. This evidence concerns the gene IGF2BP3 and cancer.